2,405 material Form 8-K filings that 2,035 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Enova International's Board authorized a new share repurchase program of up to $500 million, expiring June 30, 2028. The new program replaces the existing $400 million program, which would have expired June 30, 2027. The filing says the company is not obligated to buy any shares and the Board may change or end the program at any time.
New repurchase authorization of up to $500 million, described as the largest in Enova's history
Program expires June 30, 2028; replaces the $400 million program that would have expired June 30, 2027
Repurchases may be made in the open market or through privately negotiated transactions; no obligation to buy
WhiteFiber's indirect subsidiaries entered into a $300.0 million Term Loan Credit Agreement with Morgan Stanley Senior Funding and a lender group on November 9, 2026. No loans had been funded as of the filing date, and initial funding depends on conditions tied to the first 40 megawatts of the NC-1 data center in Madison, North Carolina. The loans are not guaranteed by WhiteFiber, Inc., but the financing adds debt tied to the project and includes covenants and a mortgage on the data center.
Facilities: $200.0 million initial term loan and $100.0 million delayed-draw term loan, both maturing on the fifth anniversary of initial funding
Interest at Term SOFR (2.00% floor) plus 6.00%, or base rate (3.00% floor) plus 5.00%, at the borrower's election
No loans funded as of the filing; initial funding is scheduled within 30 days after closing, with up to two 30-day extensions
Loans are not guaranteed by WhiteFiber, Inc.; the Operating Partnership must deliver an unsecured Phase 1 completion guarantee before initial funding
EPAM Systems entered a $500 million fixed dollar accelerated share repurchase agreement with UBS on November 9, 2026, under its $1.8 billion buyback authorization. The company received an initial delivery of 2,550,695 shares, about $400 million at the November 9 closing price, with final settlement expected in the first quarter of 2027. The final share count will depend on the volume-weighted average share price over the term of the agreement, less a discount.
Company pays $500 million to UBS under the ASR Agreement dated November 9, 2026
Initial delivery of 2,550,695 shares expected by November 10, 2026, worth $400 million at the November 9 closing price
Final settlement expected in the first quarter of 2027; final share count set on completion
Funded with cash on hand and borrowings under the existing credit facility
Community Health Systems' subsidiary CHS/Community Health Systems plans a private offer to exchange any and all of its roughly $1.24 billion of 6.875% notes due 2029 for new 10.25% senior secured notes due 2035, and to seek consents to remove substantially all restrictive covenants and certain events of default from the old notes' indenture. Supporting holders of about 52% of the old notes have agreed to tender, and the filing says the company expects to obtain the necessary consents. The offer is not yet launched and may not be completed on the stated terms.
Exchange consideration is $970 principal of new notes per $1,000 of old notes after the early tender deadline, or $1,000 with a $30 early tender premium if tendered by 5:00 p.m. New York time on November 23, 2026
Expiration date is December 10, 2026, unless extended or terminated
Supporting holders agreed to tender about $643.7 million of old notes, about 52% of the outstanding $1,244,476,000 principal
New notes mature January 15, 2035 and carry a 10.25% interest rate payable semi-annually
Globa Terra Acquisition Corp, a special purpose acquisition company, entered into a business combination agreement dated November 8, 2026 with Nature's Ledger Inc., a carbon markets and environmental assets company. The filing gives an indicated Nature's Ledger pre-money equity value of approximately $323.8 million, subject to adjustments, and a proposed PIPE financing, and completion depends on approvals, financing and other closing conditions. Shareholders also vote on a deadline extension at a November 9, 2026 meeting, where approval would trigger a $0.03 per public share trust contribution.
Business combination agreement dated November 8, 2026 with Nature's Ledger Inc.; indicated pre-money equity value of approximately $323.8 million, subject to adjustments
Structure includes a SPAC merger, a continuance under the ABCA, and an amalgamation that makes Nature's Ledger a wholly-owned subsidiary of publicly traded parent Pubco
Extension meeting on November 9, 2026 at 10:00 a.m. Eastern Time; approval triggers a $0.03 per public share sponsor trust contribution
Board may elect up to eight additional one-month extensions, potentially extending the deadline to July 9, 2027
BHAV Acquisition Corp, a special purpose acquisition company, entered into a Business Combination Agreement on November 3, 2026 with Nemi Corp., a Texas corporation with operations in India. The agreement would merge BHAV with a subsidiary of Nemi, leaving Nemi's successor company, Pubco, publicly traded, with Nemi's shareholders receiving 40,000,000 newly issued shares valued at $400 million. Completion depends on conditions including BHAV shareholder approval, regulatory approvals, registration statement effectiveness and Nasdaq listing approval.
Nemi shareholders would receive 40,000,000 newly issued Pubco shares, representing an aggregate value of $400 million.
Either party may terminate the agreement if the business combination has not closed by June 20, 2027, or a later extended date.
Closing is targeted for the first quarter of 2027, with Nemi planning to file a Form S-4 registration statement targeted for November 2026.
Nemi's founder and CEO, Anirudh Ravi Narayanan, has agreed to a two-year lock-up on his shares from closing.
Lantheus entered a definitive agreement on November 8, 2026 to sell its contract development and manufacturing organization business and its Springfield, New Jersey manufacturing facility to PharmaLogic Holdings Corp. The sale is subject to customary closing conditions, and PharmaLogic will also supply lutetium Lu 177 dotatate to Lantheus under a long-term supply agreement, which matters to shareholders as a sale of a business unit with an ongoing supply relationship.
Agreement signed November 8, 2026 to sell the CDMO business and Springfield, New Jersey facility to PharmaLogic
Lantheus will provide transition services to PharmaLogic immediately following closing
PharmaLogic's Agilera franchise will manufacture lutetium Lu 177 dotatate for Lantheus under a long-term supply agreement
The filing does not state a purchase price or expected closing date
DoubleVerify said it expects the merger under its August 6, 2026 agreement to close in the fourth quarter of 2026, subject to remaining closing conditions. Under the merger, DoubleVerify will survive as a wholly owned subsidiary of Neptune BidCo US Inc., so shareholders will be affected by the completion timing and terms of the deal.
Merger Agreement dated August 6, 2026, with Neptune BidCo US Inc. (Parent) and Wallace Merger Sub Inc. (Merger Sub)
Company expects closing during the fourth quarter of 2026, subject to satisfaction or waiver of remaining conditions
After the merger, DoubleVerify continues as the surviving corporation and a wholly owned subsidiary of Parent
Filing is made under Regulation FD and restates terms of a previously announced transaction
JBS N.V. agreed to acquire Flora Produtos de Higiene e Limpeza S.A., a Brazilian personal care and household products company, from its controlling shareholder J&F, in a transaction valued at US$542 million including assumed debt. JBS also agreed to buy Canal Rural, a Brazilian agribusiness media company, for R$88.1 million, and both deals are related-party transactions to be paid mainly in JBS Class A shares, which would add to the share count and dilute existing holders.
Flora: R$2.968 billion purchase price (US$542 million enterprise value); equity consideration of US$367 million to be paid in JBS Class A shares and/or BDRs
Canal Rural: R$88.1 million purchase price, paid to J&F in Class A shares; the Ex-99.1 release gives a US$11 million transaction value
Share issuance is based on a reference price of R$66.82916 per share (US$12.20 30-day volume-weighted average), with about 31.4 million treasury shares, or 2.9% of the share count, cited in the market presentation
Both agreements were signed November 9, 2026, and the transactions are expected to close in December 2026, subject to customary closing conditions
Effective November 1, 2026, Matthew DiCanio became President and Chief Executive Officer, William K. Newton moved to Executive Chairman, and Tanner Newton became Executive Vice President and Chief Financial Officer. The filing also details new employment agreements and restricted stock grants to named executive officers, which set severance and change-in-control terms for shareholders to weigh.
Matthew DiCanio: President and CEO, base salary $785,000, target bonus 125% of base salary
William K. Newton: Executive Chairman, base salary $550,000, target bonus 85% of base salary
Tanner Newton: EVP and CFO, base salary $425,000, target bonus 75% of base salary
Restricted stock granted November 3, 2026 vests equally over four years; DiCanio received 164,894 shares
Forge Nano Holdings said it completed its merger with HzO, Inc. on November 4, 2026, with HzO surviving as a wholly owned subsidiary. HzO stockholders were issued Forge Nano common stock as consideration, and part of that stock is held back for twelve months to secure post-closing adjustments and indemnification. The filing adds dilution from the new shares, but it does not provide HzO financial results or the effect on Forge Nano's earnings.
Merger consideration is based on a $55.0 million base purchase price, plus or minus closing cash, working capital, indebtedness and expense adjustments, divided by $10.00 per share.
Forge Nano issued 5,772,645 shares at the Effective Time, with 1,533,795 Holdback Shares held back for twelve months.
Shares received by HzO stockholders are locked up until the earlier of six months after the Effective Time or when the stock closes at or above $12.00 for 20 of 30 trading days.
HzO's CFO Jason Savod and President and COO Rachael Lerebours signed employment agreements with Forge Nano effective after the Effective Time.
GeoVax Labs appointed Tyler O'Brien as interim Chief Executive Officer and Chairman of the Board effective November 8, 2026, and added Shahin Behroyan as a director effective November 5, 2026. The filing follows the resignation of five former directors effective October 23, 2026, and it references a dispute over the termination of a former executive, Mr. Dodd, for Cause, which the company says could lead to severance or litigation. Shareholders face a leadership change at the top of the company while a permanent CEO is sought.
Tyler O'Brien appointed interim CEO and Chairman of the Board effective November 8, 2026; will serve until a permanent principal executive officer is appointed or designated
Shahin Behroyan appointed to the Board effective November 5, 2026, to fill a vacancy from the resignation of five former directors effective October 23, 2026
Behroyan is not yet on any committee; Board determined he is independent under Nasdaq Rule 5605(a)(2)
Forward-looking statements cite a possible dispute with Mr. Dodd over termination for Cause, with potential severance of three times base salary and target bonus
Genworth Financial said its Vice President and Controller, Darren W. Woodell, resigned to pursue a new opportunity, and the board appointed Chief Financial Officer Jerome T. Upton as interim Principal Accounting Officer effective November 6, 2026. The filing also notes Upton will become President and Chief Executive Officer effective January 1, 2027, following the retirement of Thomas J. McInerney.
Darren W. Woodell resigned as Vice President and Controller; the company accepted the resignation on November 6, 2026.
Jerome T. Upton, currently Executive Vice President and Chief Financial Officer, serves as interim Principal Accounting Officer until a permanent appointment is made.
Upton's compensatory arrangements will not change because of the accounting role.
Upton is slated to become President and Chief Executive Officer on January 1, 2027, when Thomas J. McInerney retires, as announced October 30, 2026.
Park Dental Partners closed its acquisition of the dental services organization supporting Village Family Dental on November 6, 2026, expanding into North Carolina, its fourth state. Base consideration was approximately $39.1 million, including 474,535 restricted shares valued at about $9.2 million, with potential aggregate consideration of up to about $46.0 million including earnouts. The company said the transaction's financial impact, including on 2026 guidance, will be shared with its earnings release on November 12, 2026.
Closed November 6, 2026; the transaction was first disclosed August 10, 2026, and adds 12 practice locations and 47 doctors.
Base consideration of approximately $39.1 million, with up to $4.6 million EBITDA-based contingent consideration and up to $2.3 million employment-contingent consideration.
Credit agreement amended to raise the maximum revolving commitment from $15.0 million to $25.0 million and add the North Carolina subsidiary as a co-borrower.
Company will release earnings November 12, 2026, with a call on November 13, and will address the transaction's impact on 2026 guidance then.
Coursera's board adopted a limited-duration stockholder rights plan, effective immediately, in response to a stockholder that its recent filings show owns about 14.7% of the common stock. The plan is designed to trigger if any person or group acquires 15% or more without board approval, which would dilute that holder's stake and could deter open-market accumulation.
The board declared a dividend of one preferred share purchase right per common share, payable November 19, 2026 to holders of record on that date.
Each right allows purchase of one one-thousandth of a preferred share for $19.50, becoming exercisable only after a person or group acquires 15% or more.
The rights expire November 7, 2027, and the board may redeem them for $0.01 per right before any person becomes an acquiring person.
The Certificate of Designations was filed with the Delaware Secretary of State on November 9, 2026.
SS&C Technologies completed a private offering of $1.2 billion of 2.75% convertible senior notes due December 1, 2031, including a $150 million option exercised in full by the initial purchasers. The company plans to use the proceeds for capped call transactions, share repurchases of about $100 million, and redeeming its $2.0 billion of 5.500% Senior Notes due 2027, which adds debt and creates potential dilution if the notes convert.
Notes issued November 6, 2026 under an indenture with Wilmington Trust, National Association, as trustee, bearing interest at 2.75% payable June 1 and December 1.
Initial conversion price of about $99.46 per share, a premium of about 25.0% over the $79.57 closing price on November 4, 2026.
Proceeds planned for about $99 million capped call cost, about $100 million of share repurchases (about 1.3 million shares), and redemption of the $2,000.0 million 2027 Senior Notes.
Company may not redeem the notes before December 5, 2029, except in a cleanup redemption.
Sonoco said CEO R. Howard Coker will retire as director, president and chief executive officer effective December 31, 2026. The board named Ernest D. Haynes III, the company's president of Global Consumer Packaging, to succeed him as CEO and as a director on that date.
Coker's retirement is effective December 31, 2026; the board accepted his notice dated November 6, 2026.
Haynes, who joined Sonoco in 1997, has an annual base salary of $1,100,004 and a bonus target of 120% of salary.
CFO Paul Joachimczyk received a $1,500,000 restricted stock unit retention award that cliff vests on the second anniversary of the grant date.
Sonoco leadership, including Coker, Haynes and Joachimczyk, will present at an R.W. Baird conference webcast on November 10, 2026, starting 7:20 a.m. Central Time.
LKQ Corporation said Salvatore A. Abbate will become President and Chief Executive Officer and join the Board effective November 9, 2026, earlier than the previously announced December 15, 2026 start date. The change ends the interim Office of the CEO led by Chairman John Mendel and Audit Committee Chair Sue Gove, which had overseen operations since October 23, 2026.
Abbate's start date moved from December 15, 2026 to November 9, 2026
Abbate becomes principal executive officer for SEC rules on November 9, 2026
Interim Office of the CEO, Mendel and Gove, which oversaw operations since October 23, concludes
Chairman Mendel said the Board has full confidence in Abbate
The merger between Mentari Therapeutics and InMed Pharmaceuticals closed on November 9, 2026, and the combined company now trades on the Nasdaq Capital Market as MTRI under the name Mentari Therapeutics, Inc. The closing included private placements with about $490 million in gross proceeds, which the company says provide runway into 2029, and the filing puts outstanding shares at about 58.3 million. The filing contains no revenue, profit, or guidance figures, so the financial effect on shareholders is defined mainly by the new capital and share count.
Private financings totaled about $490 million in gross proceeds, led by Fairmount, including conversion of $50.0 million of previously issued convertible notes plus accrued interest.
About 58.3 million shares of common stock and equivalents are outstanding after the reverse stock split, financings, and merger.
Shares began trading on Nasdaq Capital Market under the ticker MTRI on November 9, 2026.
Todd Shegog joined the Board and will chair the Audit Committee.
CNH Industrial agreed to form a joint venture with Kobelco Construction Machinery by selling a 70% interest in its Construction Equipment business for $700 million in cash, based on an agreed enterprise value of $1 billion. CNH will keep a 30% stake and says it expects to use the net cash proceeds to reduce debt, but the deal requires regulatory approvals and is expected to close by the end of 2027.
Buyers pay $700 million in cash for 70% of the business, valued at an enterprise value of $1 billion, subject to adjustments
CNH retains a 30% interest in the joint venture, with a three-year lock-up period for each party
Closing is expected by the end of 2027; either party may terminate if closing has not occurred by March 30, 2028
CNH said it will report its 2026 third quarter earnings in a separate announcement the same day
SiriusXM announced that Board director Anjali Sud, current CEO of Tubi, will become Chief Executive Officer on January 1, 2027, succeeding Jennifer C. Witz, who steps down as CEO and board member at the end of December 31, 2026. Sud's employment agreement sets a $2,600,000 base salary, a target bonus of two times salary, and equity awards including a $10,000,000 sign-on grant, which shareholders can track in the filing.
Anjali Sud, 43, becomes CEO effective January 1, 2027, and will remain on the Board
Sud's employment agreement sets a $2,600,000 base salary and a target bonus equal to two times base salary
Sud's package includes a $10,000,000 sign-on RSU grant and $4,500,000 in time-based and $4,500,000 in performance-based RSUs
Witz will serve as an advisory consultant from January 1, 2027 through December 31, 2027 at $175,000 per month
Former CEO Dr. Andrew Regan, writing on behalf of Corvus Capital Limited, told the Board in a November 5, 2026 letter that Corvus intends to make a non-binding proposal to acquire all outstanding common stock at $2.00 per share, a 96.3% premium on a post-split basis to the November 4, 2026 closing price, absent a Board proposal. The Board intends to form a special committee of independent directors with full authority over the proposal, but the committee has received no definitive terms and has made no decision, and there is no assurance any transaction will result.
Letter dated November 5, 2026, from Dr. Andrew Regan, former CEO, as a significant stockholder, on behalf of Corvus Capital Limited
Proposed price of $2.00 per share, a 96.3% premium to the November 4, 2026 closing price, on a post-split basis
Board intends to form a special committee of independent directors with full authority to consider and vote on the proposal
No definitive terms received and no decision made; the company does not commit to provide updates
Goodyear appointed Roger Wood, a current board member, as interim chief executive officer and president effective November 8, 2026, replacing Mark Stewart, who also resigned from the board. The company will search for a permanent successor while a board special committee continues a strategic review of its businesses and operations.
Wood's salary is $310,000 per month, plus a monthly restricted stock unit grant with a grant date value of $1,000,000 for up to five months or until a permanent successor is hired.
Stewart's separation is classified as a termination other than for Cause under the company's Executive Severance and Change in Control Plan.
Wood will step down as chair of the board's human capital and compensation committee and will not serve on the Human Capital and Compensation or Governance Committees while interim CEO.
Jerome Rouquet will become executive vice president and chief financial officer effective December 1, 2026, succeeding interim CFO Scott Deakin.
Azora Therapeutics appointed three new independent directors, Aida Habtezion, Paul Hastings and Thomas Soloway, effective November 3, 2026, and four directors resigned the same day, reducing the board to five members. Separately, 9,924,260 common shares were issued on conversion of Series A Preferred Stock, bringing common shares outstanding to 14,243,129 as of November 4, 2026.
Three directors appointed November 3, 2026: Aida Habtezion, M.D., Paul Hastings and Thomas Soloway; the board was reduced to five members
Four directors resigned effective November 3, 2026: J. Kermit Anderson, Cary J. Claiborne, Robertson H. Gilliland and Kevin Schuyler; Matthew Davidson was named board chair
9,924,260 common shares issued on automatic conversion of 9,924.260 Series A Preferred shares effective November 2, 2026; 3,006.341 preferred shares remain outstanding
Company has not finalized non-employee director compensation; no equity awards granted to the new directors
Atea Pharmaceuticals entered a Loan and Security Agreement with Hercules Capital on November 6, 2026, providing for senior secured term loans of up to $200.0 million, with $65.0 million drawn at closing. The loans mature on November 1, 2031, and are secured by substantially all of the company's assets, including its intellectual property, which gives shareholders a larger fixed debt obligation tied to the company's development of BEM/RZR.
Tranche 1 loan of $65.0 million was drawn on the November 6, 2026 closing date; further tranches total up to $135.0 million
Interest floats at the greater of the WSJ prime rate plus 2.35% or 9.35%, paid monthly, with interest-only payments for 48 months
Tranche 2 availability depends on completing the Phase 3 trial of BEM/RZR before a specified date in the second half of 2027
Financial covenants include a minimum cash test beginning October 1, 2027, and a performance covenant tied to FDA approval of BEM/RZR
Abeona Therapeutics acquired APT-1011, now called ABO-801, a clinical-stage treatment candidate for eosinophilic esophagitis, from Ellodi Pharmaceuticals in exchange for 4,494,383 common shares valued at $20 million, with no upfront cash. The company also agreed to sell 6,400,000 shares and pre-funded warrants for 1,600,043 shares in a private placement for about $30 million, expected to close November 10, 2026, which will add new shares and dilute existing holders.
Ellodi receives 4,494,383 shares valued at $20 million, based on a 20-day VWAP ending the trading day before the November 6, 2026 closing date, and no upfront cash.
Further payments to Ellodi include $30 million upon FDA approval of a New Drug Application, up to $30 million on sales milestones, and tiered royalties in the low to mid teen percentages.
Private placement of 6,400,000 shares at $3.75 per share plus pre-funded warrants at $3.7499, with Morgan Stanley as sole placement agent and net proceeds for general corporate purposes including ZEVASKYN.
One-third of the upfront shares unlock at each of the 6-, 12- and 18-month anniversaries of closing; resale registration for the private placement shares is due within 15 days after closing.
Charles River Laboratories agreed to acquire the bioanalysis and DMPK operations of Frontage Holdings in Exton, Pennsylvania, for approximately $470 million in cash, plus up to $75 million in performance-based payments. The company expects the deal to be neutral to non-GAAP earnings per share in 2027 and accretive after that, and expects to close in the first half of 2027, subject to shareholder and regulatory approvals.
Purchase price of approximately $470 million in cash, subject to customary closing adjustments, with additional payments of up to $75 million tied to future performance
Acquired businesses represented approximately 40% of Frontage's 2025 revenue of $256.7 million and employ approximately 340 people across two Exton sites
Expected to be neutral to non-GAAP EPS in 2027 and accretive thereafter; to be financed through Charles River's credit facility and available cash
Closing expected in the first half of 2027; Frontage is being taken private by a consortium that includes Tigermed and Dr. Song Li
Vistance Networks CEO Chuck Treadway, who has led the company since October 2020, will step down as President, CEO and board member effective February 1, 2027, after resigning on November 4, 2026. The board has launched a search for a successor and retained an executive search firm, and Treadway's severance is contingent on signing a separation agreement with a general release.
Treadway resigned November 4, 2026 and leaves the CEO role and board on February 1, 2027.
Treadway's departure is treated as a resignation for good reason under his Severance Protection Agreement, with severance contingent on a separation agreement containing a general release.
The company says it returned $16.50 per share to shareholders through special cash distributions in 2026, including a $1.50 per share distribution payable November 6, 2026.
The company released third quarter 2026 results in a separate press release issued the same day, November 5, 2026.
Datavault AI's board appointed Brett Moyer as Chief Executive Officer and President, effective immediately, after Nathaniel Bradley was removed from that role on November 1, 2026. Board changes also name Kimberly Briskey Chair and Teresa Gallo Chief Operating Officer, a shake-up that bears on how the company is run and governed.
Brett Moyer, previously CFO and a director, named CEO and President effective November 6, 2026; Nathaniel Bradley removed as CEO on November 1, 2026
Stanley Mbugua, previously Chief Accounting Officer, named Chief Financial Officer; Teresa Gallo named Chief Operating Officer
Kimberly Briskey named Chair of the Board; Christopher R. Hardt named Chair of the Audit Committee
Company says it will report third-quarter 2026 results on a date to be announced
Kontoor Brands completed the sale of its H.D. Lee Company subsidiary to ABG-Storm LLC, an affiliate of Authentic Brands Group, on November 2, 2026. The company received $750 million in cash at closing, subject to post-closing adjustments, plus up to $250 million in earnout payments tied to the Lee business's performance over five years. The filing says the company anticipates using $400 million for accelerated share repurchases and $50 million for open market repurchases.
Closing date: November 2, 2026; cash at closing of $750 million before post-closing adjustments
Pro forma estimate of cash received after adjustments: approximately $698.2 million
Earnout of up to $250 million over five years; estimated fair value at closing of $77.0 million
Planned use of proceeds: $400 million in accelerated share repurchases and $50 million in open market repurchases
BCP Investment Corporation postponed the release of its third quarter 2026 financial results and the related conference call, which were originally scheduled for November 5 and November 6, 2026. The company said the delay gives management more time to finalize financial disclosures, regulatory filings and structural terms tied to a potential strategic initiative, and that there is no assurance this will lead to a definitive agreement or transaction.
Q3 2026 results release and conference call postponed from November 5 and November 6, 2026
Delay tied to finalizing disclosures, regulatory filings and structural terms of a potential strategic initiative
Company states the delay is not related to any accounting, financial or regulatory matters
New call date and dial-in details to be issued by separate press release in the coming days
RPM International's Chairman and CEO Frank C. Sullivan announced on November 6, 2026 that he plans to retire within the next twelve to eighteen months. He will remain in his role until a successor is appointed and is expected to then stay on as Chair of the Board, as the company runs a succession planning process with its Board.
Frank C. Sullivan plans to retire in the next twelve to eighteen months, per the November 6, 2026 filing.
Sullivan has served nearly 25 years as Chairman and CEO and more than 40 years with the company.
He will remain CEO until his successor is appointed and is expected to stay on as Board Chair afterward.
Roku completed its merger with Fox Corporation on November 6, 2026, becoming a wholly owned subsidiary of FOX. Roku stockholders received $95.30 in cash and 0.9799 of a share of FOX Class A common stock per share, and trading of Roku stock on Nasdaq will halt.
The merger became effective on November 6, 2026, resulting in a change in control.
Stockholders are entitled to $95.30 in cash and 0.9799 of a FOX Class A common stock share per share.
Roku requested the removal of its Class A common stock from listing on Nasdaq.
Roku terminated its existing credit agreement dated September 16, 2024.
Bowman Consulting Group Ltd. completed its merger with Prive Parent, Inc., an affiliate of Bernhard Capital Partners, on November 6, 2026, and is now a wholly owned subsidiary of Parent. Each outstanding share was converted into the right to receive $43.00 in cash, so public shareholders no longer hold stock in the company. The company's common stock is being removed from Nasdaq and deregistered, ending its public reporting.
Each share of common stock converted into the right to receive $43.00 in cash, without interest.
The merger was funded by equity commitments from BCP funds and a debt financing commitment, per the filing.
Nasdaq was asked to suspend trading and withdraw the listing before the market opened on November 6, 2026.
Six directors, including founder Gary Bowman, resigned at the Effective Time; Mark D. Spender, Jonathan Parnell, Joe Boyer and Gary Bowman became directors of the Surviving Corporation.
Power Solutions International's Chief Financial Officer, Xun (Ken) Li, notified the board on November 3, 2026, that he will resign, effective November 27, 2026, to pursue another professional opportunity. The company said the resignation was not the result of any disagreement with the company.
Xun (Ken) Li resigns as Chief Financial Officer, also serving as principal financial and principal accounting officer
Notice to the board given November 3, 2026; resignation effective November 27, 2026
Company states the departure was not due to any disagreement
Repligen closed private exchange and subscription transactions on November 6, 2026, issuing $1.0 billion of 0.25% Convertible Senior Notes due 2031. About $541.4 million of the new notes swapped out $456.8 million of its 1.00% notes due 2028, and $458.6 million was sold for cash. The filing shows the company took on new debt with a lower coupon and a conversion price about 20% above the October 29, 2026 closing price, which could mean future share dilution if holders convert.
Issued $1.0 billion of 0.25% Convertible Senior Notes due November 1, 2031, with interest paid semi-annually starting May 1, 2027
Exchanged $456.8 million of 1.00% 2028 notes for $541.4 million of new notes; $143.2 million of 2028 notes remain outstanding
Initial conversion price of about $226.37 per share, roughly 20% above the $188.64 closing price on October 29, 2026
Up to 5,301,100 shares of common stock may be issued on conversion, including make-whole additional shares
On November 3, 2026, subsidiary The Andersons Renewables, LLC agreed to acquire Harvestone Low Carbon Partners from Energy Capital Partners for $915 million. The three ethanol plants in North Dakota and Indiana have about 215 million gallons of annual capacity, and the company plans to fund the deal with about $300 million from its revolving credit facility and $615 million of new long-term debt. Closing is expected in the fourth quarter of 2026 or early in the first quarter of 2027, subject to regulatory approvals; the company says the deal is expected to be immediately accretive to earnings per share, but the filing gives no figures for this.
Purchase price of $915 million, with about half attributed to expected 45Z and 45Q tax credit cash flows
Three ethanol plants with about 215 million gallons of annual production capacity, combined platform about 730 million gallons
Financing of about $300 million from the revolving credit facility and $615 million in new long-term debt, with committed financing from U.S. Bank and Farm Credit Mid-America
Expected closing in the fourth quarter of 2026 or early in the first quarter of 2027
Sylvamo entered a put option agreement with Midas Atlantic Partners, backed by The Najafi Companies, for a binding offer to acquire its Europe business. The buyer would take the business with an agreed level of working capital and cash, and Sylvamo would receive 20% of future distributions; no purchase price is stated. The company must complete works council and employee consultations before a final decision, and closing is expected by the end of the first quarter of 2027.
Buyer is Midas Atlantic Partners, in partnership with The Najafi Companies
Sylvamo would receive 20% of future distributions from the business in exchange for the transfer
Final decision follows consultations with works councils and employee representatives
Closing is expected by the end of the first quarter of 2027
Algorhythm Holdings' CEO and Chairman Andrew Thompson resigned effective immediately, with the board stating no disagreement over operations, policies or practices. Director Gregory D. Smith was appointed to both roles on November 2, 2026, under a CEO agreement with a base salary of $375,000 rising to $480,000 on performance conditions.
Andrew Thompson resigned as CEO and Chairman, accepted by the board on October 30, 2026.
Gregory D. Smith, age 67 and a board member since September 2026, became CEO and Chairman on November 2, 2026.
Smith's agreement provides a 2,119,542-share restricted stock award, with 1,059,771 shares vesting immediately and 1,059,771 vesting on the first anniversary of the effective date.
Severance equals two times base salary plus maximum annual bonus; the filing reports 40,848,979 common shares outstanding as of November 4, 2026.
Datavault AI's board removed Nathaniel Bradley as Chief Executive Officer and President and terminated his employment, effective immediately, on November 1, 2026. The action was approved by all directors except Mr. Bradley, who voted against it, and he continues to serve as a board member. The filing does not name a successor or an interim leader, leaving the company's top executive role open as of the filing date.
Removal effective November 1, 2026, with employment terminated immediately
Board action approved by all directors other than Mr. Bradley, who voted against it
Mr. Bradley remains a board member until the next annual meeting or earlier resignation or removal
ANI Pharmaceuticals entered a 364-day senior bridge credit facility of up to $676 million with JPMorgan Chase Bank, N.A. as administrative agent. The facility will be used to finance its recommended public cash offer for Egetis Therapeutics shares, convertible loan and warrants, valued at about SEK 5.6 billion, or approximately $559.9 million, and to refinance ANI's existing term loans and some Egetis debt, which adds significant borrowing and secured obligations for ANI shareholders.
Facility allows borrowings up to $676 million and matures 364 days after initial funding
Initial margin of 1.75% for ABR loans and 2.75% for adjusted term SOFR loans
Offer price is SEK 11.25 per Egetis share; total value about SEK 5.6 billion, or $559.9 million
Completion requires holders of at least 90% of Egetis shares (fully diluted) to tender and regulatory clearances; undertakings covering 42.2% of shares expire if the offer is not declared unconditional by March 31, 2027
NextEra Energy filed unaudited pro forma combined financial information and Dominion Energy's financial statements for the pending merger, which was agreed on May 15, 2026. The filing estimates total merger consideration at $62.1 billion, based on NEE's $83.71 closing price on October 30, 2026, and shows lower pro forma per-share earnings than NEE's historical figures. The deal still requires several regulatory approvals and other closing conditions, and the company says the pro forma figures are illustrative only.
Each Dominion Energy share converts into $360 million in aggregate cash, plus 0.8138 NEE shares, pro rata
Estimated merger consideration is $62.1 billion, based on about 738 million NEE shares at $83.71
Pro forma nine-month 2026 basic EPS is $4.16, versus NEE's historical $4.84
Closing requires HSR clearance and approvals from FERC, NRC, and the Virginia, North Carolina and South Carolina regulators
Meta Platforms completed a $15.0 billion offering of five U.S. dollar senior note series maturing from 2031 to 2056, with fixed rates from 5.850% to 7.500%. Underwriters also exercised in full their option to buy 6,000,000 additional Class A common shares from an offering priced in late October 2026, with forward sale agreements covering those shares. The filing does not state how the proceeds will be used, so the added debt and share sales are the main points for shareholders to weigh.
Five senior note series: $3.25 billion due 2031, $3.25 billion due 2033, $4.0 billion due 2036, $1.75 billion due 2046 and $2.75 billion due 2056
Notes were issued under an indenture dated August 9, 2022 with U.S. Bank Trust Company, National Association, as trustee, and a sixth supplemental indenture dated November 5, 2026
Underwriters exercised their option in full on November 4, 2026 for 6,000,000 additional Class A common shares, with additional forward sale agreements on similar terms
Underwriting agreement dated November 3, 2026 with Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC as representatives
Axon Enterprise announced an incremental minority investment of about $1.2 billion in drone maker Skydio, which it expects will raise Axon's fully diluted ownership from about 15% to about 37%. The primary purchase closed on November 5, 2026, and the remaining transactions are expected to close in the fourth quarter of 2026 and first quarter of 2027. The deal adds a large cash outlay and share issuance for Axon, and Axon also becomes Skydio's exclusive public safety distributor in the U.S. and Canada.
Primary purchase closed November 5, 2026: 25,000,000 Series G preferred shares at $10.19617 per share, for about $254.9 million in aggregate.
Total investment is about $1.2 billion, with about $720 million (approximately 60%) expected in cash and the remainder in Axon common stock.
Axon stock issued for the investment is capped at 19.99% of shares outstanding before the primary closing.
Tender offer to begin within ten business days of the primary closing; the Committed Secondary is expected to close in the first quarter of 2027.
Sunrise Realty Trust (SUNS) completed its merger with Southern Realty Trust on November 5, 2026. Southern Realty Trust stockholders received 1.45 SUNS shares and $0.05 in cash from SUNS Manager for each share they held, and SUNS issued 8,464,975 shares, bringing shares outstanding to 21,980,826. The company also amended its management agreement, cutting the incentive fee and hurdle rate and reducing the base management fee, which the filing says benefits all SUNS stockholders, while former Southern Realty Trust holders now own about 38.5% of the combined company.
Merger closed November 5, 2026; each Southern Realty Trust share converted into 1.45 SUNS shares plus $0.05 in cash from SUNS Manager
SUNS issued 8,464,975 shares, resulting in 21,980,826 shares outstanding; former Southern Realty Trust stockholders own about 38.5%
Incentive fee reduced from 20% to 17.5% and hurdle rate from 8.0% to 7.0%; base management fee cut by $250,000 per quarter for four quarters, or $1.0 million in total
Pro forma as of June 30, 2026, the combined company had about $534 million of total assets and about $285 million of book value
CVR Energy agreed to sell 10,515,248 common shares at $47.55 each, with net proceeds of about $490.0 million before offering expenses, closing November 5, 2026. The company plans to use the proceeds with cash on hand and other financing to fund its acquisition of the St. Paul Park and Mandan refineries from Marathon Petroleum subsidiaries, redeem its 5.750% Senior Notes due 2028, and pay related fees.
Offering: 10,515,248 shares at $47.55 per share, with a 30-day option for up to 1,577,287 additional shares
Net proceeds of approximately $490.0 million; offering closed November 5, 2026
Proceeds to fund the St. Paul Park and Mandan refinery acquisition and redeem 2028 Notes; if the acquisition does not close, proceeds go to general corporate purposes
Selling stockholder IEP Energy Holding LLC is not included in the priced offering; the company receives no proceeds from its shares
Krispy Kreme's board approved an amendment to CEO Joshua Charlesworth's employment agreement on October 30, 2026. The change raises his annual cash target bonus from 100% to 150% of base salary, effective November 1, 2026, and increases his annual restricted stock unit grant from $1,000,000 to $2,500,000, starting with the 2027 grant. The filing does not state a financial reason for the change, but it raises the potential pay of the company's top executive.
Target annual cash bonus rises from 100% to 150% of base salary, effective November 1, 2026.
Annual restricted stock unit grant increases from $1,000,000 to $2,500,000, beginning with the 2027 annual grant.
Changes were approved by the Board of Directors on October 30, 2026 and disclosed in a filing dated November 5, 2026.
PNC's board appointed Alexander E. C. Overstrom, currently executive vice president and head of Retail Banking, as chief financial officer effective March 1, 2027. Robert Q. Reilly, the current CFO, will become executive vice chairman on the same date, serving as a senior executive advisor to Chairman and CEO William S. Demchak. The filing does not report financial results, so it contains no direct measure of business performance.
Alexander E. C. Overstrom, 42, joined PNC in 2014 and has led Retail Banking since July 2022.
Robert Q. Reilly has been CFO since 2013 and remains in the role until March 1, 2027.
Permanent successor for PNC Retail Banking will be named in the near future.
Xcel Energy issued $2.5 billion of 2.625% convertible senior notes due December 15, 2027, including $300 million from the initial purchasers' option. The notes are convertible into Xcel common stock at an initial conversion price of about $87.26 per share, and conversions can be settled in cash, shares, or a mix. Because the notes are convertible, they could add up to 31,513,750 shares of common stock to the share count if holders convert at the maximum rate.
Issued $2,500,000,000 of 2.625% Convertible Senior Notes due December 15, 2027, dated November 5, 2026
Initial conversion rate of 11.4596 shares per $1,000 principal, or about $87.26 per share
Up to 31,513,750 shares may be issued on conversion at the initial maximum conversion rate of 12.6055 shares per $1,000
Notes cannot be redeemed by Xcel Energy before maturity and carry no sinking fund
HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed on November 5, 2026 a public offering of $6.5 billion of senior unsecured notes in seven series maturing from 2028 to 2056, fully guaranteed by HCA Healthcare. The filing does not state how the proceeds will be used, but the offering adds $6.5 billion of debt obligations for the company.
Seven series totaling $6.5 billion; the largest is $1.5 billion of 6.000% senior notes due November 15, 2036.
Fixed-rate coupons range from 5.200% to 6.500%, and $300 million of floating-rate notes mature November 3, 2028.
Underwriting agreement dated November 2, 2026 with Mizuho Securities USA LLC, Barclays Capital Inc., BofA Securities, Inc. and Wells Fargo Securities, LLC as representatives.
Holders can require repurchase at 101% of principal only upon both a qualifying ratings downgrade and a change of control.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.